Correlation Between Prestige Biologics and Green Cross
Can any of the company-specific risk be diversified away by investing in both Prestige Biologics and Green Cross at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prestige Biologics and Green Cross into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prestige Biologics Co and Green Cross Lab, you can compare the effects of market volatilities on Prestige Biologics and Green Cross and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prestige Biologics with a short position of Green Cross. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prestige Biologics and Green Cross.
Diversification Opportunities for Prestige Biologics and Green Cross
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Prestige and Green is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Prestige Biologics Co and Green Cross Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Cross Lab and Prestige Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prestige Biologics Co are associated (or correlated) with Green Cross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Cross Lab has no effect on the direction of Prestige Biologics i.e., Prestige Biologics and Green Cross go up and down completely randomly.
Pair Corralation between Prestige Biologics and Green Cross
Assuming the 90 days trading horizon Prestige Biologics Co is expected to generate 1.42 times more return on investment than Green Cross. However, Prestige Biologics is 1.42 times more volatile than Green Cross Lab. It trades about 0.05 of its potential returns per unit of risk. Green Cross Lab is currently generating about -0.03 per unit of risk. If you would invest 302,000 in Prestige Biologics Co on September 19, 2024 and sell it today you would earn a total of 208,000 from holding Prestige Biologics Co or generate 68.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Prestige Biologics Co vs. Green Cross Lab
Performance |
Timeline |
Prestige Biologics |
Green Cross Lab |
Prestige Biologics and Green Cross Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Prestige Biologics and Green Cross
The main advantage of trading using opposite Prestige Biologics and Green Cross positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prestige Biologics position performs unexpectedly, Green Cross can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cross will offset losses from the drop in Green Cross' long position.Prestige Biologics vs. Samsung Biologics Co | Prestige Biologics vs. SK Bioscience Co | Prestige Biologics vs. Green Cross Lab | Prestige Biologics vs. MedPacto |
Green Cross vs. Samsung Biologics Co | Green Cross vs. SK Bioscience Co | Green Cross vs. MedPacto | Green Cross vs. Prestige Biologics Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world |